Matthew D. Burke PhD

Dr. Matthew Burke serves as Head of Drug Delivery in the Platform Technologies & Science Department at GlaxoSmithKline. He leads a group guiding the drug delivery strategy at GSK which includes internal development and application of technologies as well as external evaluation. Dr. Burke also serves as a project lead for an asset in late phase clinical development and is a master subject matter expert on oral modified release and continuous manufacturing.

Dr. Burke has worked at multiple sites in the US and UK within GSK, has approximately 30 articles, patents and symposium presentations. He has served as an adjunct professor at North Carolina State University Biomolecular and Chemical Engineering department and the University of North Carolina at Chapel Hill School of Pharmacy and received his Ph.D. in Oral Colonic Drug Delivery Systems.